Quick answer
How is cagrilintide reconstituted and stored in the lab? Keep the sealed lyophilized vial refrigerated at 2–8 °C for near-term work and at −20 °C for long-term holding, away from heat, moisture and light. Let the vial reach room temperature before opening, run the diluent down the glass wall, and swirl slowly rather than shaking, because this lipidated amylin analog foams and self-associates when agitated. Use bacteriostatic water for a stock that will be entered more than once and sterile water for a stock that is divided and frozen straight away. Work out volumes with the reconstitution calculator, check the solution for clarity, label it, and log every step.
Cagrilintide is not a typical short research peptide. It is a long, acylated analog of amylin with an internal disulfide ring, and both features change how the vial should be handled on the bench. This guide explains the reasoning behind each handling decision so that a stock prepared on day one behaves the same way in the last assay of a series. The material is supplied for laboratory research use only; not for human consumption.
What arrives: the lyophilized cagrilintide vial
The cagrilintide product page lists a single 10 mg size, supplied as lyophilized powder in a sealed clear glass research vial, with purity stated as ≥98% by HPLC. Freeze-drying removes water by sublimation and leaves the peptide as a dry solid; the process is described in what is lyophilization. A freeze-dried peptide normally presents as a white to off-white cake or a loose powder at the bottom of the vial. A cake that has broken up or coated the wall in transit is a cosmetic change, not a quality signal. A solid that looks wet, glassy, collapsed into a sticky film or discolored is different and deserves a note in the receiving record before the vial is used.
| Item | What the product page states | Why it matters at the bench |
|---|---|---|
| Vial size | 10 mg | The mass that every concentration calculation starts from |
| Purity | ≥98% (HPLC) | Chromatographic purity is not the same as net peptide content; counterions and residual water also occupy mass |
| Supplied form | Lyophilized powder | Dry solid is the most stable state; reconstitution starts the clock |
| Storage line | Refrigerate at 2–8 °C; −20 °C for long-term; protect from heat, moisture and light | Defines the two storage tiers used throughout this guide |
| Container | Sealed clear glass research vial | Clear glass gives no light protection, so the box or a foil wrap does that job |
| Sequence / identity | Reported on the certificate of analysis, where published | Identity is confirmed from the document, not assumed from the label |
Before the seal is broken, compare the lot number on the vial with the entry in the COA library. A certificate is listed there where one has been published; where it is, it reports HPLC purity and identity, and how to read a COA explains each field. If no certificate is yet listed for the lot in hand, record that fact rather than leaving the field blank. Background on the molecule itself is collected in the cagrilintide research overview.
The chemistry that drives cagrilintide handling
The medicinal-chemistry paper that introduced cagrilintide (Kruse and colleagues, 2021) describes a long-acting analog built on the amylin scaffold and carrying a fatty diacid side chain. Three structural features of that design matter to anyone preparing a stock solution.
A fatty acid side chain makes the molecule an amphiphile
Acylation gives the peptide a hydrophobic tail and a hydrophilic body. Molecules of this kind collect at air–water and plastic–water interfaces, form foam when shaken and tend to self-associate in solution. Practical consequences: dissolution can be slower than for a small cationic peptide, bubbles are a sign of rough handling rather than a harmless artifact, and losses to tube walls and pipette tips are a real consideration at low concentration. The same fatty acid binds albumin, so the free fraction of cagrilintide in an assay medium that contains serum or albumin differs from that in a protein-free buffer. That is an experimental-design point, but it begins with how the stock is diluted.
An amylin backbone carries an aggregation history
Native amylin is one of the most fibril-prone peptides known, a property reviewed by Westermark and colleagues (2011). Amylin analogs are engineered specifically to suppress that behavior, and cagrilintide was designed with reduced fibrillation in mind. Engineering lowers the risk; it does not license careless handling. Heat, vigorous agitation, repeated freezing and long residence in solution are the same stresses that drive aggregation in any amyloid-related sequence, so they are the stresses to minimize here.
A disulfide ring and asparagine residues
Amylin-family peptides contain an intramolecular disulfide bond near the N-terminus that closes a small ring, and a C-terminal amide. A disulfide is stable in mildly acidic to neutral water but can exchange or break down in alkaline solution and is cleaved outright by reducing agents such as DTT, TCEP or β-mercaptoethanol. Stock solutions should therefore never be prepared in, or diluted through, a reducing buffer unless reduction is the purpose of the experiment. The amylin scaffold also contains several asparagine residues. Asparagine deamidation through a succinimide intermediate is a well-characterized, pH- and temperature-dependent reaction in peptides (Geiger and Clarke, 1987), and it proceeds faster in neutral-to-alkaline solution than in the dry state. The amylin scaffold contains no methionine or tryptophan, so oxidation of those side chains is less of a concern for this compound than aggregation and deamidation are.
Solvent choice: bacteriostatic water versus sterile water
For cagrilintide the diluent decision has two parts: what keeps the stock microbiologically sound, and what keeps a lipidated, aggregation-aware peptide in clear solution. The general concepts are covered in bacteriostatic water explained; the table applies them to this compound.
| Diluent | Fits this situation | Strength | Caution for cagrilintide |
|---|---|---|---|
| Bacteriostatic water (benzyl alcohol preservative) | A stock vial whose stopper will be pierced on several occasions | Preservative suppresses microbial growth between entries | Benzyl alcohol is an assay variable in cell work, so run a matched vehicle control; preservatives can also promote aggregation of some peptides, which is a reason to inspect the stock at each use |
| Sterile water | A stock that is divided into single-use portions and frozen the same day | No additives; simplest background for analytical and cell-based work | No preservative, so it is unsuitable as a refrigerated multi-entry vial |
| Assay buffer or culture medium | Final working dilution only, made on the day | Matches the pH and ionic strength the assay needs | Salts and neutral pH favor self-association and deamidation over time; not a storage medium |
| Buffers containing reducing agents | Not appropriate for stocks | — | Reduction opens the disulfide ring and changes the molecule being studied |
If a freshly prepared solution stays hazy after a few minutes of standing and gentle swirling, resist the two common reflexes of warming and vortexing. Both add exactly the stresses that amylin-type peptides tolerate least. Give the vial more time, and if haze persists, record it and consult the lot documentation rather than forcing the material into solution. The general technique is laid out in how to reconstitute a lyophilized peptide.
Reconstitution workflow, step by step
- Equilibrate. Move the sealed vial from cold storage to the bench and let it reach room temperature before opening. Opening a cold vial pulls humid air onto a hygroscopic solid.
- Plan the arithmetic first. Decide the stock concentration the experiment needs and obtain the diluent volume from the calculator. Write the planned figures in the notebook before any liquid is drawn.
- Clean the closures. Wipe both stoppers with an alcohol swab and allow them to dry fully.
- Add the diluent slowly. Direct the stream against the inner glass wall so it runs down to the cake instead of striking it. A hard stream on a lipidated peptide produces foam immediately.
- Dissolve without agitation. Tilt and roll the vial, then let it stand. Do not shake, vortex or sonicate.
- Inspect. Hold the vial against a light and a dark background in turn. Proceed only when the liquid is clear.
- Divide or store. Either portion the stock into low-binding tubes for freezing or return a preserved multi-entry vial to the refrigerator.
- Label and log. Compound, lot, diluent, concentration, date and initials go on the container and in the record at once, not later.
Storage tiers for powder and solution
The product page gives one storage line: refrigerate at 2–8 °C; −20 °C for long-term; protect from heat, moisture and light. The table expands that line into the states a vial passes through. It deliberately gives no day-counts for cagrilintide solutions, because none have been published for this research material.
| State | Temperature tier | Handling notes |
|---|---|---|
| Sealed lyophilized vial, in active use soon | 2–8 °C | Keep in its box, away from the refrigerator door and from light |
| Sealed lyophilized vial, reserve stock | −20 °C | Preferred for long holding; avoid frost-free units whose defrost cycles warm the contents |
| Lyophilized vial in transit or on the bench | Ambient, briefly | Return to cold storage on receipt; log the arrival condition |
| Stock in bacteriostatic water | 2–8 °C | Multi-entry use; swab the stopper each time; inspect before each withdrawal |
| Stock in sterile water | Frozen in single-use portions at −20 °C | No preservative, so do not keep it as a refrigerated working vial |
| Working dilution in buffer or medium | Prepared on the day | Discard what is left; do not return it to storage |
More detail on the general logic of each tier is in storing research peptides and how long do reconstituted peptides last.
Freeze–thaw cycles and aliquoting
Freezing a peptide solution is a stress event. As ice forms, the peptide and any solutes are concentrated into a shrinking liquid phase, the pH of that phase can shift, and a large ice–liquid interface appears (Bhatnagar and colleagues, 2007). For a surface-active molecule with an aggregation-prone ancestry, each of those changes pushes toward self-association. One freeze and one thaw is the cycle to plan for.
Aliquoting is the method that makes a single cycle possible. The stock is divided, immediately after reconstitution, into portions sized for one experiment each, so that no tube is ever returned to the freezer. Thaw a portion in the refrigerator or on ice, mix it by slow inversion because solutes stratify during freezing, inspect it, and use it. If a tube must be refrozen, write the cycle count on it and carry that count into the experimental record so that an odd result can be traced.
Light, moisture and adsorption to surfaces
Moisture. Water is the reactant in deamidation and the plasticizer that mobilizes a dry cake. A vial opened while cold, or stored with a punctured stopper in a humid refrigerator, takes up moisture that shortens the life of the remaining solid.
Light. Clear glass transmits room light and ultraviolet. Aromatic side chains absorb in that range, and photo-oxidation is a recognized forced-degradation pathway for peptides and proteins (Hawe and colleagues, 2012). Keeping vials boxed is sufficient protection.
Adsorption. Peptide loss to glass and plastic is measurable and depends on the peptide and the surface (Goebel-Stengel and colleagues, 2011). A lipidated peptide is especially inclined to coat hydrophobic plastics. Use low-binding tubes and tips, avoid storing very dilute solutions, keep the number of container transfers small, and make serial dilutions immediately before use. Where a protocol allows carrier protein in the working buffer, remember that albumin both reduces surface loss and binds the fatty acid chain.
Visual quality checks before every use
- Clarity: the solution should be clear. Opalescence or a milky cast suggests self-association or precipitation.
- Particulates: look for specks, fibers or gel-like strands, which can indicate aggregate or stopper debris.
- Color: the solution should be colorless. A tint that develops over time is a reason to retire the stock.
- Foam: persistent foam means the solution was agitated; let it settle and handle more gently next time.
- Closure: a cored or leaking stopper compromises sterility regardless of how the liquid looks.
A visual check detects gross failure only. Soluble oligomers, deamidated species and small losses of concentration are invisible, which is why a clear vial is a necessary condition rather than proof of integrity. Laboratories that need certainty re-run HPLC on an aged stock; the principles are described in cagrilintide purity testing.
Records and labelling
A reconstituted peptide with no label is an unknown. At minimum the container should carry the compound name, lot number, diluent, concentration, preparation date and the preparer's initials. The notebook entry should add the lot's certificate status, the appearance of the cake on receipt, the calculated and actual diluent volume, the appearance of the solution, the storage location, each date the vial was entered, and the freeze–thaw count of any aliquot used. These details cost a minute and are the only way to explain a drifting result weeks later.
What not to do
- Do not shake, vortex or sonicate; foam and shear favor aggregation.
- Do not warm a hazy solution to clear it.
- Do not open a vial straight from the freezer.
- Do not store stock in saline buffer, culture medium or any reducing buffer.
- Do not keep an unpreserved sterile-water solution as a refrigerated multi-entry vial.
- Do not refreeze thawed portions as routine practice.
- Do not leave clear vials exposed on the bench under room lighting.
- Do not combine cagrilintide with another peptide in one stock vial; solution conditions that suit one compound may not suit the other. Co-formulation questions are discussed in CagriSema combination research.
What stability data are, and are not, published
Honesty about evidence matters here. The published literature on cagrilintide describes its design, receptor pharmacology and behavior in formulated development material. It does not provide a validated shelf life for a research-grade lyophilized vial reconstituted in bacteriostatic or sterile water, and no degradation rate, percentage loss or expiry period for that situation should be quoted as fact. What can be said with confidence comes from general peptide science: the dry state is far more stable than solution (Manning and colleagues, 2010; Wang, 1999), lower temperature slows chemical change, and aggregation risk rises with agitation, heat and freeze–thaw cycling. The conventional time limit applied to preserved multi-entry containers is a microbiological convention about the preservative, not a measurement of cagrilintide's chemical stability. Where an experiment depends on exact concentration over weeks, the sound options are fresh preparation, single-use frozen portions, or analytical re-verification.
Related reading
- Cagrilintide research overview
- Cagrilintide vs pramlintide, a comparison of two amylin analogs
- Where to buy cagrilintide for research and what documentation to expect
- Storing research peptides
Frequently asked questions
What does lyophilized cagrilintide look like?
A white to off-white cake or loose powder at the base of a sealed clear glass vial. A cake that has broken up in transit is normal. A solid that looks wet, sticky, collapsed or discolored should be noted in the receiving record before use.
Should cagrilintide be reconstituted with bacteriostatic water or sterile water?
Bacteriostatic water suits a stock vial that will be entered several times, because its preservative limits microbial growth. Sterile water suits a stock that is divided into single-use portions and frozen the same day, or work where benzyl alcohol would interfere with the assay.
How much diluent should be added to a cagrilintide vial?
That depends on the stock concentration an experiment calls for. The vial mass is fixed, so the volume only sets the concentration. Use the reconstitution calculator to do the arithmetic and write the figures down before starting.
Why should cagrilintide not be shaken?
It carries a fatty acid side chain and behaves as an amphiphile, so shaking creates foam and large air–water interfaces. Those conditions, together with its amylin-derived backbone, favor self-association. Slow swirling and standing time dissolve it more safely.
At what temperature should cagrilintide be stored?
The product page states: refrigerate at 2–8 °C, −20 °C for long-term, and protect from heat, moisture and light. Sealed powder for near-term work stays refrigerated; reserve vials go to the freezer.
How long does reconstituted cagrilintide last?
No validated shelf life has been published for research-grade cagrilintide reconstituted in bacteriostatic or sterile water. Laboratories rely on general practice: keep solutions cold, limit time in solution, freeze single-use portions for longer work and re-verify by HPLC when concentration is critical.
How many freeze–thaw cycles can a cagrilintide solution take?
Plan for one. Freezing concentrates the peptide and creates ice interfaces that encourage aggregation, so the stock should be divided into single-use portions that are thawed once and not refrozen.
Can cagrilintide be stored in a buffer that contains a reducing agent?
No. Amylin-family peptides contain an intramolecular disulfide bond, and agents such as DTT, TCEP or β-mercaptoethanol break it, which changes the molecule under study.
Does cagrilintide stick to plastic tubes?
Lipidated peptides are inclined to adsorb to hydrophobic surfaces, and the loss is proportionally largest in dilute solutions. Low-binding tubes and tips, few transfers and dilution immediately before use keep the loss small.
What does a properly reconstituted cagrilintide solution look like?
Clear and colorless, with no particles, strands or lasting foam. Haze, visible material or a developing tint are reasons to stop and document the observation instead of using the stock.
References
- Kruse T, Hansen JL, Dahl K, et al. Development of cagrilintide, a long-acting amylin analogue. J Med Chem. 2021;64(15):11183-11194. doi:10.1021/acs.jmedchem.1c00565
- Westermark P, Andersson A, Westermark GT. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol Rev. 2011;91(3):795-826. doi:10.1152/physrev.00042.2009
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. doi:10.1007/s11095-009-0045-6
- Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int J Pharm. 1999;185(2):129-188. doi:10.1016/S0378-5173(99)00152-0
- Hawe A, Wiggenhorn M, van de Weert M, Garbe JHO, Mahler HC, Jiskoot W. Forced degradation of therapeutic proteins. J Pharm Sci. 2012;101(3):895-913. doi:10.1002/jps.22812
- Geiger T, Clarke S. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. J Biol Chem. 1987;262(2):785-794. PMID: 3805008
- Bhatnagar BS, Bogner RH, Pikal MJ. Protein stability during freezing: separation of stresses and mechanisms of stabilization. Pharm Dev Technol. 2007;12(5):505-523. doi:10.1080/10837450701481157
- Goebel-Stengel M, Stengel A, Taché Y, Reeve JR Jr. The importance of using the optimal plasticware and glassware in studies involving peptides. Anal Biochem. 2011;414(1):38-46. doi:10.1016/j.ab.2011.02.009
